Keyphrases
Neonatal Jaundice
100%
Phototherapy
97%
Low-middle Income Countries
74%
Nigeria
70%
Neonate
59%
Glucose-6-phosphate Dehydrogenase (G6PD)
49%
Resource-limited Settings
47%
Sunlight
46%
Jaundice
46%
Acute Bilirubin Encephalopathy
45%
Low-resource Settings
42%
Irradiance
38%
Kernicterus
37%
Total Bilirubin
33%
Severe Hyperbilirubinemia
33%
Neonatal Hyperbilirubinemia
31%
Nigerians
27%
Pediatric
26%
Phototherapy Device
25%
Global Health
22%
Bubble Continuous Positive Airway Pressure
21%
Healthcare Professionals
19%
Global Pediatrics
18%
Meta-analysis
18%
Systematic Meta-analysis
18%
Hyperbilirubinemia
17%
Maternal Milk
17%
Procedural Adaptations
17%
Exchange Transfusion
17%
Bilirubin
16%
Risk Factors
16%
Adaptation
15%
Limited Resources
15%
University of Minnesota
15%
Milk Volume
15%
Respiratory Distress
15%
Bilirubin Neurotoxicity
15%
Resource-constrained Settings
14%
Irradiance Sensor
14%
Nursery
13%
Severe Neonatal Hyperbilirubinemia
13%
Neonatal Mortality
12%
Umbilical Cord Blood
12%
Global Health Electives
12%
Pediatric Residency
12%
Kernicterus Spectrum Disorder
12%
Conventional Phototherapy
12%
Southwest Nigeria
11%
Pediatric Trauma Care
11%
Solar Power
11%
Medicine and Dentistry
Phototherapy
96%
Neonatal Jaundice
87%
Kernicterus
80%
Pediatrics
74%
Low and Middle Income Countries
63%
Neonates
56%
Hyperbilirubinemia
55%
Bilirubin
47%
Neonatal Hyperbilirubinemia
42%
Glucose-6-Phosphate Dehydrogenase Deficiency
38%
Jaundice
37%
Health Care Cost
30%
Continuous Positive Airway Pressure
29%
Neonatal Infant
29%
Intensive Care
19%
Exchange Blood Transfusion
19%
Glucose 6 Phosphate Dehydrogenase
17%
Disease
17%
Respiratory Distress
14%
Injury
14%
Childbirth
13%
Diagnosis
13%
Meta-Analysis
12%
Systematic Review
12%
Cord Blood
12%
Newborn Mortality
12%
Prevalence
12%
Randomized Controlled Trial
11%
Pediatric Trauma
11%
Human Milk
11%
Infection
11%
Spectrum Disorder
10%
Newborn Morbidity
9%
Pediatrics Patient
9%
Carboxyhemoglobin
9%
Neurologic Disease
9%
Allele
8%
COVID-19
8%
Low Birth Weight
7%
Rhesus Incompatibility
7%
Health Care Provider
7%
Drug Therapy
7%
Triage
7%
Analysis of Variance
6%
Medicine
6%
Oxidoreductase
6%
Noninferiority Trial
6%
Prematurity
6%
Limb
6%
Infancy
6%